Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board

MILWAUKEE - PrZen -- Qscription Technologies Inc., a U.S. market-entry company for international MedTech and SaMD AI companies, today announced that Joanna Krause, MD, MRMD has joined its Clinical Advisory Board as a Founding Member.

Dr. Joanna Krause is a board-certified diagnostic radiologist and MR safety specialist. She retired from the U.S. Navy Medical Corps as a Commander in 2025. Most recently, she served as Medical Director of MRI and Chair of the MRI Safety Committee at Naval Medical Center San Diego, where she was named the Navy's 2022 Senior Radiologist of the Year. She previously served as Chief of Diagnostic Radiology at Fort Belvoir Community Hospital and held a faculty appointment as Assistant Professor of Radiology at the Uniformed Services University, teaching medical students and residents. Dr. Krause is a Diplomate of the American Board of Radiology and the American Board of Magnetic Resonance Safety and has completed Harvard Medical School's Executive Education program, AI in Health Care: From Strategies to Implementation.

As a Founding Member of the Clinical Advisory Board, Dr. Krause will advise Qscription on the clinical evaluation and validation of imaging AI, MR safety, workflow and adoption, education, and clinical strategy.

"Dr. Krause brings deep experience in diagnostic radiology and MR safety, together with formal training in how AI is put into practice in health care," said Anurag Velekkatt, Project Manager and VP of MedTech at Qscription Technologies. "Her perspective will help us hold the imaging AI we evaluate to the standard radiologists expect in their own reading rooms."

Former military service and institutional affiliations are listed for identification only and do not imply endorsement by any organization named above.